| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 629,723 | 700,496 | 663,150 | 810,593 | | Cost of Revenue | 481,109 | 527,700 | 511,114 | 617,134 | | | Gross Profit | 148,614 | 172,796 | 152,036 | 193,459 | | | Operating Expenses | | Research Development | 15,891 | 17,841 | 16,471 | 20,795 | | Selling General and Administrative | 93,127 | 110,571 | 97,291 | 128,712 | | Non Recurring |
-
|
-
|
-
| 435 | | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 39,596 | 44,384 | 38,274 | 43,517 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 6,040 | 7,695 | (19,717) | (2,556) | | Earnings Before Interest And Taxes | 45,636 | 52,079 | 18,557 | 39,348 | | Interest Expense | 8,224 | 7,786 | 9,958 | 12,872 | | Income Before Tax | 37,412 | 44,293 | 8,599 | 26,476 | | Income Tax Expense | 6,397 | 12,424 | 2,136 | 12,464 | | Minority Interest | (751) | (1,284) | (2,109) | (1,613) | | | | Net Income From Continuing Ops | 34,408 | 30,585 | 4,354 | 14,012 | | | Non-recurring Events | | Discontinued Operations | (37,419) | (155) | (2,706) | (12,954) | | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (7,155) | 30,430 | 1,648 | 1,058 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($7,155) | $30,430 | $1,648 | $1,058 |
|
0.51% Nasdaq 
Income Statement
